متابعة
Michael Iglesia
Michael Iglesia
بريد إلكتروني تم التحقق منه على wustl.edu
عنوان
عدد مرات الاقتباسات
عدد مرات الاقتباسات
السنة
Comprehensive molecular portraits of human breast tumours
Brigham & Women’s Hospital & Harvard Medical School Chin Lynda 9 11 Park ...
Nature 490 (7418), 61-70, 2012
117202012
Molecular heterogeneity and response to neoadjuvant human epidermal growth factor receptor 2 targeting in CALGB 40601, a randomized phase III trial of paclitaxel plus …
LA Carey, DA Berry, CT Cirrincione, WT Barry, BN Pitcher, LN Harris, ...
Journal of Clinical Oncology 34 (6), 542-549, 2016
4202016
Genomic analysis of immune cell infiltrates across 11 tumor types
MD Iglesia, JS Parker, KA Hoadley, JS Serody, CM Perou, BG Vincent
Journal of the National Cancer Institute 108 (11), djw144, 2016
3432016
Prognostic B-cell signatures using mRNA-seq in patients with subtype-specific breast and ovarian cancer
MD Iglesia, BG Vincent, JS Parker, KA Hoadley, LA Carey, CM Perou, ...
Clinical Cancer Research 20 (14), 3818-3829, 2014
3032014
Claudin-low bladder tumors are immune infiltrated and actively immune suppressed
J Kardos, S Chai, LE Mose, SR Selitsky, B Krishnan, R Saito, MD Iglesia, ...
JCI insight 1 (3), 2016
2262016
Treg depletion potentiates checkpoint inhibition in claudin-low breast cancer
NA Taylor, SC Vick, MD Iglesia, WJ Brickey, BR Midkiff, KP McKinnon, ...
The Journal of clinical investigation 127 (9), 3472-3483, 2017
1562017
Spatially restricted drivers and transitional cell populations cooperate with the microenvironment in untreated and chemo-resistant pancreatic cancer
D Cui Zhou, RG Jayasinghe, S Chen, JM Herndon, MD Iglesia, P Navale, ...
Nature genetics 54 (9), 1390-1405, 2022
1422022
Tumor-specific retargeting of an oncogenic transcription factor chimera results in dysregulation of chromatin and transcription
M Patel, JM Simon, MD Iglesia, SB Wu, AW McFadden, JD Lieb, IJ Davis
Genome research 22 (2), 259-270, 2012
1322012
Functional Annotation of ESR1 Gene Fusions in Estrogen Receptor-Positive Breast Cancer
JT Lei, J Shao, J Zhang, M Iglesia, DW Chan, J Cao, M Anurag, P Singh, ...
Cell reports 24 (6), 1434-1444. e7, 2018
1192018
Assembly-based inference of B-cell receptor repertoires from short read RNA sequencing data with V’DJer
LE Mose, SR Selitsky, LM Bixby, DL Marron, MD Iglesia, JS Serody, ...
Bioinformatics 32 (24), 3729-3734, 2016
742016
Epigenetic regulation during cancer transitions across 11 tumour types
NV Terekhanova, A Karpova, WW Liang, A Strzalkowski, S Chen, Y Li, ...
Nature 623 (7986), 432-441, 2023
682023
Therapy Sequencing in Patients With Advanced Neuroendocrine Neoplasms
RP Riechelmann, RG Taboada, VHF de Jesus, M Iglesia, NA Trikalinos
American Society of Clinical Oncology Educational Book 43, e389278, 2023
132023
Tumour evolution and microenvironment interactions in 2D and 3D space
CK Mo, J Liu, S Chen, E Storrs, ALN Targino da Costa, A Houston, ...
Nature 634 (8036), 1178-1186, 2024
72024
A phase II study of palbociclib plus letrozole plus trastuzumab as neoadjuvant treatment for clinical stages II and III ER+ HER2+ breast cancer (PALTAN)
FO Ademuyiwa, DW Northfelt, T O’Connor, E Levine, J Luo, Y Tao, J Hoog, ...
NPJ Breast Cancer 9 (1), 1, 2023
52023
Differential chromatin accessibility and transcriptional dynamics define breast cancer subtypes and their lineages
MD Iglesia, RG Jayasinghe, S Chen, NV Terekhanova, JM Herndon, ...
Nature Cancer 5 (11), 1713-1736, 2024
22024
Phase I trial of CA-4948, an IRAK4 inhibitor, in combination with FOLFOX/PD-1 inhibitor+/-trastuzumab for untreated unresectable gastric and esophageal cancer.
H Park, M Iglesia, KS Pedersen, P Grierson, ZI Hu, R Suresh, BR Tan, ...
Journal of Clinical Oncology 40 (16_suppl), TPS4168-TPS4168, 2022
12022
Abstract PD8-03: ESR1 gene fusions drive endocrine therapy resistance and metastasis in breast cancer
JT Lei, J Shao, J Zhang, M Iglesia, DW Chan, J Cao, M Anurag, P Singh, ...
Cancer Research 78 (4_Supplement), PD8-03-PD8-03, 2018
12018
The novel claudin-low molecular subtype of high-grade urothelial bladder cancer is highly immunogenic yet immunosuppressed
BG Vincent, W Kim, J Kardos, S Chai, J Parker, L Mose, S Selitsky, ...
Cancer Research 76 (14_Supplement), 5120-5120, 2016
12016
Research briefing
M Iglesia, L Ding
Nature 5, 1605-1606, 2024
2024
Allele-specific KRAS mutations as prognostic biomarkers in mucinous adenocarcinoma of the appendix and colorectal cancer.
MM Khushman, HM Abushukair, S Alhushki, M Iglesia, KH Lim, X Liu, ...
Journal of Clinical Oncology 42 (16_suppl), 3628-3628, 2024
2024
يتعذر على النظام إجراء العملية في الوقت الحالي. عاود المحاولة لاحقًا.
مقالات 1–20